SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-095852
Filing Date
2021-07-26
Accepted
2021-07-26 16:18:13
Documents
3
Period of Report
2021-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123169-1_8k.htm 8-K 32842
2 EXHIBIT 10.1 tm212316910d1_ex10-1.htm EX-10.1 72629
3 EXHIBIT 99.1 tm212316910d1_ex99-1.htm EX-99.1 15046
  Complete submission text file 0001104659-21-095852.txt   121804
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 211114362
SIC: 2834 Pharmaceutical Preparations